InVivo Therapeutics Holdings Corp. (NVIV) is priced at $0.74 after the most recent trading session. At the very opening of the session, the stock price was $0.662 and reached a high price of $0.7489, prior to closing the session it reached the value of $0.66. The stock touched a low price of $0.65.
Recently in News on March 12, 2021, InVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference. InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, which runs from March 17 – March 19 from 9:00 am – 5:00 pm ET. Dr. Toselli’s presentation will provide an overview of the company and highlight key business updates for the company. You can read further details here
InVivo Therapeutics Holdings Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.0000 on 02/16/21, with the lowest value was $0.6095 for the same time period, recorded on 05/13/21.
InVivo Therapeutics Holdings Corp. (NVIV) full year performance was -44.79%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, InVivo Therapeutics Holdings Corp. shares are logging -70.99% during the 52-week period from high price, and 48.70% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $2.55.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1008355 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the InVivo Therapeutics Holdings Corp. (NVIV) recorded performance in the market was -8.67%, having the revenues showcasing -58.44% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 23.73M, as it employees total of 6 workers.
Analysts verdict on InVivo Therapeutics Holdings Corp. (NVIV)
During the last month, 0 analysts gave the InVivo Therapeutics Holdings Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.0343, with a change in the price was noted +0.1448. In a similar fashion, InVivo Therapeutics Holdings Corp. posted a movement of +24.34% for the period of last 100 days, recording 4,021,597 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NVIV is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
InVivo Therapeutics Holdings Corp. (NVIV): Technical Analysis
Raw Stochastic average of InVivo Therapeutics Holdings Corp. in the period of last 50 days is set at 16.28%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.71%. In the last 20 days, the company’s Stochastic %K was 25.88% and its Stochastic %D was recorded 19.00%.
Let’s take a glance in the erstwhile performances of InVivo Therapeutics Holdings Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -8.67%. Additionally, trading for the stock in the period of the last six months notably improved by 31.19%, alongside a downfall of -44.79% for the period of the last 12 months. The shares increased approximately by 9.88% in the 7-day charts and went up by -0.01% in the period of the last 30 days. Common stock shares were lifted by -58.44% during last recorded quarter.